Virpax Pharmaceuticals In... (VRPX)
0.21
-0.03 (-12.50%)
At close: Mar 03, 2025, 12:17 PM
Virpax Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 9.14M | 19M | 36.84M | 54.8K | 41.54K | 48.37K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | 392.34K | n/a | n/a |
| Receivables | n/a | n/a | n/a | n/a | 1.39K | n/a |
| Inventory | n/a | n/a | n/a | n/a | 3.33K | n/a |
| Other Current Assets | 702.98K | 678.37K | 2.73M | 18.27K | 3.79K | 13.13K |
| Total Current Assets | 9.63M | 19.67M | 39.57M | 73.07K | 46.72K | 61.5K |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | n/a | n/a | n/a | 392.34K | n/a | n/a |
| Total Assets | 9.63M | 19.67M | 39.57M | 465.41K | 46.72K | 61.5K |
| Account Payables | n/a | 37.64K | 19.84K | 22.11K | 3.5K | 6.55K |
| Deferred Revenue | n/a | n/a | n/a | -1.05M | -3.5 | -6.55K |
| Short-Term Debt | n/a | n/a | n/a | 543.99K | 1.26M | 500K |
| Other Current Liabilities | 7.69M | 3.06M | 2.06M | 3.08M | 1.5M | 740.21K |
| Total Current Liabilities | 7.69M | 3.09M | 2.09M | 3.66M | 2.78M | 1.25M |
| Long-Term Debt | n/a | n/a | n/a | 1.02M | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 1.09K | n/a | 1.02M | n/a | 500K |
| Total Liabilities | 7.69M | 3.09M | 2.09M | 4.68M | 2.78M | 1.25M |
| Total Debt | n/a | n/a | n/a | 1.57M | 1.26M | 500K |
| Common Stock | 12.00 | 117.00 | 117.00 | 31.00 | 30.00 | 29.00 |
| Retained Earnings | -59.54M | -44.35M | -22.7M | -10.65M | -6.31M | -3M |
| Comprehensive Income | -0.00 | -0.00 | -0.00 | n/a | -0.00 | n/a |
| Shareholders Equity | 1.93M | 16.58M | 37.48M | -4.22M | -2.73M | -1.19M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |